Skip to main content
Erschienen in: Tumor Biology 6/2016

29.12.2015 | Original Article

Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival

verfasst von: Anu Yadav, Annapurna Gupta, Saurabh Yadav, Neeraj Rastogi, Sushma Agrawal, Ashok Kumar, Vijay Kumar, Sanjeev Misra, Balraj Mittal

Erschienen in: Tumor Biology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Gallbladder cancer (GBC) is the most common malignancy of the biliary tract with adverse prognosis and poor survival. Wnt signaling plays an important role in embryonic development and regeneration of tissues in all the species. Deregulation of expression and mutations in this pathway may lead to disease state such as cancer. In this study, we assessed the association of common germline variants of Wnt pathway genes (SFRP2, SFRP4, DKK2, DKK3, WISP3, APC, β-catenin, AXIN-2, GLI-1) to evaluate their contribution in predisposition to GBC and treatment outcomes. The study included 564 GBC patients and 250 controls. Out of 564, 200 patients were followed up for treatment response and survival. Tumor response (RECIST 1.1) was recorded in 116 patients undergoing non-adjuvant chemotherapy (NACT). Survival was assessed by Kaplan-Meier curve and Cox-proportional hazard regression. Single locus analysis showed significant association of SFRP4 rs1802073G > T [p value = 0.0001], DKK2 rs17037102C > T [p value = 0.0001], DKK3 rs3206824C > T [p value = 0.012], APC rs4595552 A/T [p value = 0.021], APC rs11954856G > T [p value = 0.047], AXIN-2 rs4791171C > T [p value = 0.001], β-catenin rs4135385A > G [p value = 0.031], and GLI-1 rs222826C > G [p value = 0.001] with increased risk of GBC. Gene-gene interaction using GMDR analysis predicted APC rs11954856 and AXIN2 rs4791171 as significant in conferring GBC susceptibility. Cox-proportional hazard model showed GLI-1 rs2228226 CG/GG and AXIN-2 rs4791171 TT genotype higher hazard ratio. In recursive partitioning, AXIN-2 rs4791171 TT genotype showed higher mortality and hazard. Most of studied genetic variants influence GBC susceptibility. APC rs11954856, GLI-1 rs2228226, and AXIN-2 rs4791171 were found to be associated with poor survival in advanced GBC patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, et al. Functional and structural diversity of the human Dickkopf gene family. Gene. 1999;238:301–13.CrossRefPubMed Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, et al. Functional and structural diversity of the human Dickkopf gene family. Gene. 1999;238:301–13.CrossRefPubMed
2.
Zurück zum Zitat Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA, et al. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A. 1997;94:2859–63.CrossRefPubMedPubMedCentral Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA, et al. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A. 1997;94:2859–63.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Yang J, Zhang W, Evans PM, Chen X, He X, Liu C. Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem. 2006;281:17751–7.CrossRefPubMed Yang J, Zhang W, Evans PM, Chen X, He X, Liu C. Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem. 2006;281:17751–7.CrossRefPubMed
4.
Zurück zum Zitat Hurvitz JR, Suwairi WM, Van Hul W, El-Shanti H, Superti-Furga A, Roudier J, et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet. 1999;23:94–8.CrossRefPubMed Hurvitz JR, Suwairi WM, Van Hul W, El-Shanti H, Superti-Furga A, Roudier J, et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet. 1999;23:94–8.CrossRefPubMed
5.
Zurück zum Zitat Huang W, Pal A, Kleer CG. On how CCN6 suppresses breast cancer growth and invasion. J Cell Commun Signal. 2012;6:5–10.CrossRefPubMed Huang W, Pal A, Kleer CG. On how CCN6 suppresses breast cancer growth and invasion. J Cell Commun Signal. 2012;6:5–10.CrossRefPubMed
6.
Zurück zum Zitat Liu CZ, Yang JT, Yoon JW, Villavicencio E, Pfendler K, Walterhouse D, et al. Characterization of the promoter region and genomic organization of GLI, a member of the Sonic hedgehog-Patched signaling pathway. Gene. 1998;209:1–11.CrossRefPubMed Liu CZ, Yang JT, Yoon JW, Villavicencio E, Pfendler K, Walterhouse D, et al. Characterization of the promoter region and genomic organization of GLI, a member of the Sonic hedgehog-Patched signaling pathway. Gene. 1998;209:1–11.CrossRefPubMed
7.
Zurück zum Zitat Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O’Brien SJ, et al. Identification of an amplified, highly expressed gene in a human glioma. Science. 1987;236:70–3.CrossRefPubMed Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O’Brien SJ, et al. Identification of an amplified, highly expressed gene in a human glioma. Science. 1987;236:70–3.CrossRefPubMed
8.
Zurück zum Zitat Páez D, Gerger A, Zhang W, Yang D, Labonte MJ, Benhanim L, et al. Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence. Pharmacogenomics J. 2014;14:142–50.CrossRefPubMed Páez D, Gerger A, Zhang W, Yang D, Labonte MJ, Benhanim L, et al. Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence. Pharmacogenomics J. 2014;14:142–50.CrossRefPubMed
9.
Zurück zum Zitat Mostowska A, Pawlik P, Sajdak S, Markowska J, Pawałowska M, Lianeri M, et al. An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population. Mol Diagn Ther. 2014;18:85–91.CrossRefPubMed Mostowska A, Pawlik P, Sajdak S, Markowska J, Pawałowska M, Lianeri M, et al. An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population. Mol Diagn Ther. 2014;18:85–91.CrossRefPubMed
10.
Zurück zum Zitat Alanazi MS, Parine NR, Shaik JP, Alabdulkarim HA, Ajaj SA, Khan Z. Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients. PLoS One. 2013;8:e59555.CrossRefPubMedPubMedCentral Alanazi MS, Parine NR, Shaik JP, Alabdulkarim HA, Ajaj SA, Khan Z. Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients. PLoS One. 2013;8:e59555.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Szkandera J, Pichler M, Absenger G, Stotz M, Weissmueller M, Samonigg H, et al. A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients. Clin Cancer Res. 2014;20:1687–97.CrossRefPubMed Szkandera J, Pichler M, Absenger G, Stotz M, Weissmueller M, Samonigg H, et al. A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients. Clin Cancer Res. 2014;20:1687–97.CrossRefPubMed
12.
Zurück zum Zitat Wang S, Tian Y, Wu D, Zhu H, Luo D, Gong W, et al. Genetic variation of CTNNB1 gene is associated with susceptibility and prognosis of gastric cancer in a Chinese population. Mutagenesis. 2012;27:623–30.CrossRefPubMed Wang S, Tian Y, Wu D, Zhu H, Luo D, Gong W, et al. Genetic variation of CTNNB1 gene is associated with susceptibility and prognosis of gastric cancer in a Chinese population. Mutagenesis. 2012;27:623–30.CrossRefPubMed
13.
Zurück zum Zitat Sharma KL, Yadav A, Gupta A, Tulsayan S, Kumar V, Misra S, et al. Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population. Tumour Biol. 2014;35:2583–9.CrossRefPubMed Sharma KL, Yadav A, Gupta A, Tulsayan S, Kumar V, Misra S, et al. Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population. Tumour Biol. 2014;35:2583–9.CrossRefPubMed
14.
Zurück zum Zitat Yadav A, Gupta A, Rastogi N, Agrawal S, Kumar A, Kumar V, et al. Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival. Tumour Biol. 2015 Yadav A, Gupta A, Rastogi N, Agrawal S, Kumar A, Kumar V, et al. Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival. Tumour Biol. 2015
15.
16.
Zurück zum Zitat Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007;80:1125–37.CrossRefPubMedPubMedCentral Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007;80:1125–37.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14(15):1837–51.PubMed Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14(15):1837–51.PubMed
18.
19.
20.
Zurück zum Zitat Hirata H, Hinoda Y, Nakajima K, Kikuno N, Yamamura S, Kawakami K, et al. Wnt antagonist gene polymorphisms and renal cancer. Cancer. 2009;115:4488–503.CrossRefPubMedPubMedCentral Hirata H, Hinoda Y, Nakajima K, Kikuno N, Yamamura S, Kawakami K, et al. Wnt antagonist gene polymorphisms and renal cancer. Cancer. 2009;115:4488–503.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Frank B, Hoffmeister M, Klopp N, Illig T, Chang-Claude J, Brenner H. Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer. Carcinogenesis. 2010;31:1381–6.CrossRefPubMed Frank B, Hoffmeister M, Klopp N, Illig T, Chang-Claude J, Brenner H. Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer. Carcinogenesis. 2010;31:1381–6.CrossRefPubMed
22.
Zurück zum Zitat Wong HL, Peters U, Hayes RB, Huang WY, Schatzkin A, Bresalier RS, et al. Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer. 2010;46:2457–66.CrossRefPubMedPubMedCentral Wong HL, Peters U, Hayes RB, Huang WY, Schatzkin A, Bresalier RS, et al. Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer. 2010;46:2457–66.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Guerreiro CS, Cravo ML, Brito M, Vidal PM, Fidalgo PO, Leitão CN. The D1822V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons. Am J Clin Nutr. 2007;85:1592–7.PubMed Guerreiro CS, Cravo ML, Brito M, Vidal PM, Fidalgo PO, Leitão CN. The D1822V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons. Am J Clin Nutr. 2007;85:1592–7.PubMed
24.
Zurück zum Zitat Wang X, Goode EL, Fredericksen ZS, Vierkant RA, Pankratz VS, Liu-Mares W, et al. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:2101–8.CrossRefPubMedPubMedCentral Wang X, Goode EL, Fredericksen ZS, Vierkant RA, Pankratz VS, Liu-Mares W, et al. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:2101–8.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Kanzaki H, Ouchida M, Hanafusa H, Yano M, Suzuki H, Aoe M, et al. Single nucleotide polymorphism of the AXIN2 gene is preferentially associated with human lung cancer risk in a Japanese population. Int J Mol Med. 2006;18:279–84.PubMed Kanzaki H, Ouchida M, Hanafusa H, Yano M, Suzuki H, Aoe M, et al. Single nucleotide polymorphism of the AXIN2 gene is preferentially associated with human lung cancer risk in a Japanese population. Int J Mol Med. 2006;18:279–84.PubMed
26.
Zurück zum Zitat Ma C, Liu C, Huang P, Kaku H, Chen J, Guo K, et al. Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer. Oncol Lett. 2014;8:789–94.PubMedPubMedCentral Ma C, Liu C, Huang P, Kaku H, Chen J, Guo K, et al. Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer. Oncol Lett. 2014;8:789–94.PubMedPubMedCentral
27.
Zurück zum Zitat Liu D, Li L, Yang Y, Liu W, Wu J. The Axin2 rs2240308 polymorphism and susceptibility to lung cancer in a Chinese population. Tumour Biol. 2014;35:10987–91.CrossRefPubMed Liu D, Li L, Yang Y, Liu W, Wu J. The Axin2 rs2240308 polymorphism and susceptibility to lung cancer in a Chinese population. Tumour Biol. 2014;35:10987–91.CrossRefPubMed
28.
Zurück zum Zitat Mihalatos M, Danielides I, Belogianni J, Harokopos E, Papadopoulou E, Kalimanis G, et al. Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients. Cancer Genet Cytogenet. 2003;141:65–70.CrossRefPubMed Mihalatos M, Danielides I, Belogianni J, Harokopos E, Papadopoulou E, Kalimanis G, et al. Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients. Cancer Genet Cytogenet. 2003;141:65–70.CrossRefPubMed
29.
Zurück zum Zitat Silva AL, Dawson SN, Arends MJ, Guttula K, Hall N, Cameron EA, et al. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. BMC Cancer. 2014;14:891.CrossRefPubMedPubMedCentral Silva AL, Dawson SN, Arends MJ, Guttula K, Hall N, Cameron EA, et al. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. BMC Cancer. 2014;14:891.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Park H, Jung HY, Choi HJ, Kim DY, Yoo JY, Yun CO, et al. Distinct roles of DKK1 and DKK2 in tumor angiogenesis. Angiogenesis. 2014;17:221–34.CrossRefPubMed Park H, Jung HY, Choi HJ, Kim DY, Yoo JY, Yun CO, et al. Distinct roles of DKK1 and DKK2 in tumor angiogenesis. Angiogenesis. 2014;17:221–34.CrossRefPubMed
31.
Zurück zum Zitat Valdora F, Banelli B, Stigliani S, Pfister SM, Moretti S, Kool M, et al. Epigenetic silencing of DKK3 in medulloblastoma. Int J Mol Sci. 2013;14:7492–505.CrossRefPubMedPubMedCentral Valdora F, Banelli B, Stigliani S, Pfister SM, Moretti S, Kool M, et al. Epigenetic silencing of DKK3 in medulloblastoma. Int J Mol Sci. 2013;14:7492–505.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Hauer K, Calzada-Wack J, Steiger K, Grunewald TG, Baumhoer D, Plehm S, et al. DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma. Cancer Res. 2013;73:967–77.CrossRefPubMed Hauer K, Calzada-Wack J, Steiger K, Grunewald TG, Baumhoer D, Plehm S, et al. DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma. Cancer Res. 2013;73:967–77.CrossRefPubMed
33.
Zurück zum Zitat Zhu J, Zhang S, Gu L, Di W. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma. Carcinogenesis. 2012;33:2334–43.CrossRefPubMed Zhu J, Zhang S, Gu L, Di W. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma. Carcinogenesis. 2012;33:2334–43.CrossRefPubMed
34.
Zurück zum Zitat Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003;1653:1–24.PubMed Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003;1653:1–24.PubMed
35.
Zurück zum Zitat Furuuchi K, Tada M, Yamada H, Kataoka A, Furuuchi N, Hamada J, et al. Somatic mutations of the APC gene in primary breast cancers. Am J Pathol. 2000;156:1997–2005.CrossRefPubMedPubMedCentral Furuuchi K, Tada M, Yamada H, Kataoka A, Furuuchi N, Hamada J, et al. Somatic mutations of the APC gene in primary breast cancers. Am J Pathol. 2000;156:1997–2005.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Jin Z, Tamura G, Tsuchiya T, Sakata K, Kashiwaba M, Osakabe M, et al. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer. 2001;85:69–73.CrossRefPubMedPubMedCentral Jin Z, Tamura G, Tsuchiya T, Sakata K, Kashiwaba M, Osakabe M, et al. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer. 2001;85:69–73.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Kimura Y, Furuhata T, Mukaiya M, Kihara C, Kawakami M, Okita K, et al. Frequent beta-catenin alteration in gallbladder carcinomas. J Exp Clin Cancer Res. 2003;22:321–8.PubMed Kimura Y, Furuhata T, Mukaiya M, Kihara C, Kawakami M, Okita K, et al. Frequent beta-catenin alteration in gallbladder carcinomas. J Exp Clin Cancer Res. 2003;22:321–8.PubMed
38.
Zurück zum Zitat Rashid A, Gao YT, Bhakta S, Shen MC, Wang BS, Deng J, et al. Beta-catenin mutations in biliary tract cancers: a population-based study in China. Cancer Res. 2001;61:3406–9.PubMed Rashid A, Gao YT, Bhakta S, Shen MC, Wang BS, Deng J, et al. Beta-catenin mutations in biliary tract cancers: a population-based study in China. Cancer Res. 2001;61:3406–9.PubMed
39.
Zurück zum Zitat Eklof Spink K, Fridman SG, Weis WI. Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex. EMBO J. 2001;20:6203–12.CrossRefPubMed Eklof Spink K, Fridman SG, Weis WI. Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex. EMBO J. 2001;20:6203–12.CrossRefPubMed
40.
Zurück zum Zitat Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, et al. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells. 1998;3:395–403.CrossRefPubMed Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, et al. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells. 1998;3:395–403.CrossRefPubMed
41.
Zurück zum Zitat Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.CrossRef Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.CrossRef
42.
Zurück zum Zitat Jeon SY, Kim DC, Song KH, Kim KH. Expression patterns of Gli-1, Pleckstrin homology-like domain, family a, member 1, transforming growth factor-β1/β2, and p63 in sebaceous and follicular tumors. Ann Dermatol. 2014;26:713–21.CrossRefPubMedPubMedCentral Jeon SY, Kim DC, Song KH, Kim KH. Expression patterns of Gli-1, Pleckstrin homology-like domain, family a, member 1, transforming growth factor-β1/β2, and p63 in sebaceous and follicular tumors. Ann Dermatol. 2014;26:713–21.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Werner CA, Döhner H, Joos S, Trümper LH, Baudis M, Barth TF, et al. High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am J Pathol. 1997;151:335–42.PubMedPubMedCentral Werner CA, Döhner H, Joos S, Trümper LH, Baudis M, Barth TF, et al. High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am J Pathol. 1997;151:335–42.PubMedPubMedCentral
44.
Zurück zum Zitat Lees CW, Zacharias WJ, Tremelling M, Noble CL, Nimmo ER, Tenesa A, et al. Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways. PLoS Med. 2008;5:e239.CrossRefPubMedPubMedCentral Lees CW, Zacharias WJ, Tremelling M, Noble CL, Nimmo ER, Tenesa A, et al. Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways. PLoS Med. 2008;5:e239.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Mullor JL, Dahmane N, Sun T, Ruiz i Altaba A. Wnt signals are targets and mediators of Gli function. Curr Biol. 2001;11:769–73.CrossRefPubMed Mullor JL, Dahmane N, Sun T, Ruiz i Altaba A. Wnt signals are targets and mediators of Gli function. Curr Biol. 2001;11:769–73.CrossRefPubMed
46.
Zurück zum Zitat Xu J, Huang G, Zhang Z, Zhao J, Zhang M, Wang Y, et al. Up-regulation of glioma-associated oncogene homolog 1 expression by serum starvation promotes cell survival in ER-positive breast cancer cells. Cell Physiol Biochem. 2015;36:1862–76.CrossRefPubMed Xu J, Huang G, Zhang Z, Zhao J, Zhang M, Wang Y, et al. Up-regulation of glioma-associated oncogene homolog 1 expression by serum starvation promotes cell survival in ER-positive breast cancer cells. Cell Physiol Biochem. 2015;36:1862–76.CrossRefPubMed
47.
Zurück zum Zitat Tseng RC, Lin RK, Wen CK, Tseng C, Hsu HS, Hsu WH, et al. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis. Oncogene. 2008;27:4488–96.CrossRefPubMed Tseng RC, Lin RK, Wen CK, Tseng C, Hsu HS, Hsu WH, et al. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis. Oncogene. 2008;27:4488–96.CrossRefPubMed
48.
Zurück zum Zitat Stewart DJ, Chang DW, Ye Y, Spitz M, Lu C, Shu X, et al. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. Pharmacogenomics J. 2014;14:509–22.CrossRefPubMedPubMedCentral Stewart DJ, Chang DW, Ye Y, Spitz M, Lu C, Shu X, et al. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. Pharmacogenomics J. 2014;14:509–22.CrossRefPubMedPubMedCentral
Metadaten
Titel
Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival
verfasst von
Anu Yadav
Annapurna Gupta
Saurabh Yadav
Neeraj Rastogi
Sushma Agrawal
Ashok Kumar
Vijay Kumar
Sanjeev Misra
Balraj Mittal
Publikationsdatum
29.12.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 6/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4728-9

Weitere Artikel der Ausgabe 6/2016

Tumor Biology 6/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.